title: Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin.
authors.forename: C M
authors.initials: CM
authors.lastname: Zwaan
authors.forename: D
authors.initials: D
authors.lastname: Reinhardt
authors.forename: H
authors.initials: H
authors.lastname: Jürgens
authors.forename: D R
authors.initials: DR
authors.lastname: Huismans
authors.forename: K
authors.initials: K
authors.lastname: Hählen
authors.forename: O P
authors.initials: OP
authors.lastname: Smith
authors.forename: A
authors.initials: A
authors.lastname: Biondi
authors.forename: E R
authors.initials: ER
authors.lastname: van Wering
authors.forename: J
authors.initials: J
authors.lastname: Feingold
authors.forename: G J L
authors.initials: GJ
authors.lastname: Kaspers
mesh_terms: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015703:Antigens, CD / Q000097:blood*; D015214:Antigens, Differentiation, Myelomonocytic / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D002872:Chromosome Deletion; D005260:Female; D000079982:Gemtuzumab; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D007223:Infant; D007621:Karyotyping; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics*; D063268:Sialic Acid Binding Ig-like Lectin 3
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; D000922:Immunotoxins; D063268:Sialic Acid Binding Ig-like Lectin 3; D000079982:Gemtuzumab